Claraphi Advisory Network’s AtriCure ATRC Stock Holding History

Claraphi Advisory Network’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-425	Closed	-$14K	–	348
2020 Q1	$14K	Buy	+425	New	+$15.3K	0.01%	703

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Claraphi Advisory Network's ATRC Position: Q2 2020 in Review

Claraphi Advisory Network sold out of AtriCure (ATRC) in Q2 2020, closing a stake of 425 shares — an estimated $14K sold.

Claraphi Advisory Network first reported a position in ATRC in Q1 2020 and held it in 1 quarter. The position peaked at $14K in Q1 2020. 188 funds tracked by Wall St. Rank hold ATRC as of Q2 2020.

Claraphi Advisory Network reported no remaining AtriCure position as of Q2 2020 after selling out during the quarter.
Claraphi Advisory Network sold 425 AtriCure shares in Q2 2020, an estimated $14K.
Claraphi Advisory Network first reported a position in AtriCure in Q1 2020 and held it in 1 quarter.
Claraphi Advisory Network's AtriCure position peaked at $14K in Q1 2020.
188 funds tracked by Wall St. Rank held AtriCure as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.